As part of its advocacy program in Europe, ACRO submits regulatory comments to European officials. This comment letter, submitted by ACRO to European Commission in 2023 about Multi-Stakeholder Recommendations for transitioning Clinical Trials from the Clinical Trials Directive to the Clinical Trials Regulation can be found below.